diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: Control group: During the intervention and six-month follow-up, the control group will not receive training program and after the end of study pamphlets and videos teaching demo will
Lifestyle
Control group: During the intervention and six-month follow-up, the control group will not receive training program and after the end of study pamphlets and videos teaching demo will be available to
Intervention group: The intervention group will be trans-theoretical model of education based on stages of change model.
Educational content for people who pre contemplation, contemplation and de
Sponsors
Vice-Dean for Reserch and Technology Tabriz University Of Medical Science
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with type 2 diabetes, age range 30-70 years; patients with type 2 diabetes with a history of over a year; the use of blood glucose lowering drugs ;Satisfaction in the study; absence of kidney disease, liver and mental problems and learning, vision and hearing problems; A1C = 7% or FPG= 126 mg / dL ; BMI>25 kg/m2 ;ability to read and write; regular attendance in classes Exclusion criteria: the use of insulin in patients with type 2 diabetes; pregnant women with type 2 diabetes / plan to become pregnant or breast-feeding; Persons who have already passed the training course healthy lifestyle as a model; patients who were undergoing surgery for weight loss.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose (FPG). Timepoint: Before intervention At the end of the seventh week and 6 months after the intervention. Method of measurement: Photometry with Commercial Kits (Pars azmon).;Glycosylated hemoglobin(A1C). Timepoint: Early intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Chromatography.;Blood glucose 2 hours after breakfast( 2-h PG). Timepoint: Early intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Photometry with Commercial Kits (Pars Azmoon).;Tri glyceride(TG). Timepoint: Early intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Photometry with Commercial Kits (Pars Azmoon).;Total Cholesterol(TC). Timepoint: Early intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Photometry with Commercial Kits (Pars Azmoon).;HDL-C. Timepoint: Early intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Photometry with Commercial Kits (Pars Azmoon).;LDL–C. Timepoint: Early intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Fried-Wald formula.;Irisin. Timepoint: Early intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: ELISA kit for measuring enzyme-linked immunosorbent (Zlbio, Germany).;Serum insulin. Timepoint: Early intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: ELISA kit for measuring enzyme-linked immunosorbent (monobind, America ).;Betatrophin. Timepoint: Early intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: ELISA kit for measuring enzyme-linked immunosorbent (Zlbio, Germany). | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: Before the intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: scale RASA.;Body mass index(BMI). Timepoint: Before the intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: With formula.;Blood Pressure. Timepoint: Before the intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Manometer EmsiG.;The type and number of drugs. Timepoint: Before the intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: With Question.;Position on Stage of Change. Timepoint: Before the intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Questionnaire Stage of Change.;Energy. Timepoint: Before the intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Recall Food 24 -hour.;Macronutrients. Timepoint: Before the intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Recall Food 24 -hour.;Exercise Intensity. Timepoint: Before the intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Questionnaire IPAQ.;Exercise Duration. Timepoint: Before the intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Questionnaire IPAQ.;Exercise Frequency. Timepoint: Before the intervention, the end of the seventh week and after 6 months follow-up. Method of measurement: Questionnaire IPAQ. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Zare
Nutrition faculty, Tabriz university Of Medical sciences
Outcome results
None listed